Bisphosphonates for preventing and treating osteoporosis in men

  • Protocol
  • Intervention

Authors

  • Ie-Wen Sim,

    1. The University of Melbourne, NorthWest Academic Centre, Victoria, Australia
    Search for more papers by this author
  • Peter Ebeling,

    1. The University of Melbourne, NorthWest Academic Centre, Victoria, Australia
    Search for more papers by this author
  • Rachelle Buchbinder

    Corresponding author
    1. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Monash Department of Clinical Epidemiology, Cabrini Hospital, Malvern, Victoria, Australia
    • Rachelle Buchbinder, Monash Department of Clinical Epidemiology, Cabrini Hospital, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Suite 41, Cabrini Medical Centre, 183 Wattletree Road, Malvern, Victoria, 3144, Australia. rachelle.buchbinder@monash.edu.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the benefit and harm of bisphosphonate therapy for the prevention and treatment of osteoporosis in men.